India will revisit the dosage interval for Covishield vaccine and take appropriate action based on emerging data, NK Arora, chairperson of the working group of immunisation advisory body NTAGI, said.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback